• Biodegradable Ionizable Polyesters for VEGF mRNA Delivery in

  2026-07-13

  This study introduces a three-armed biodegradable polyester with ionization-mimicking cationic lipid properties, offering a safer and more effective vehicle for VEGF mRNA delivery in critical limb ischemia (CLI). The material surpasses conventional LNPs in both transfection efficiency and therapeutic bioactivity, providing a promising platform for regenerative gene therapy.

• EPZ-6438: Potent EZH2 Inhibitor for Epigenetic Cancer Resear

  2026-07-13

  EPZ-6438 is a highly selective EZH2 inhibitor with robust efficacy in preclinical cancer models. It induces potent reductions in H3K27me3 and demonstrates superior activity in HPV-associated malignancies. Its validated performance and reproducibility make it a cornerstone tool in epigenetic cancer research.

• Structural Insights into FADD-Procaspase-8-cFLIP DED Complex

  2026-07-12

  This study presents the first atomic-resolution structures of the human FADD-procaspase-8-cFLIP DED complex, revealing how these assemblies regulate apoptosis and necroptosis. The findings clarify the mechanistic basis for death domain signaling in cell fate decisions, with implications for cancer research and targeted apoptosis modulation.

• AAL-993: Precision VEGF Receptor Inhibitor for In Vivo Tumor

  2026-07-10

  Explore how AAL-993, a potent VEGF receptor inhibitor, advances in vivo research on tumor angiogenesis and metastasis. This article provides deep insights into its mechanism, protocol integration, and unique value for translational studies.

• LMP7 in Airway Epithelium: Resolving Rhinovirus-Driven Infla

  2026-07-09

  This study demonstrates that the immunoproteasome subunit LMP7 in airway epithelial cells plays a pivotal anti-inflammatory and antiviral role during rhinovirus infection. By employing conditional knockout mice and CRISPR-modified human cells, the findings reveal LMP7's unique capacity to limit viral burden and cytokine-mediated inflammation, suggesting new strategies for managing respiratory viral exacerbations.

• Sodium Phosphate Dibasic: Optimizing Biological Assay Buffer

  2026-07-09

  Sodium phosphate dibasic (Na2HPO4) offers unmatched pH stability and reproducibility as a core buffer in aquatic toxicity and molecular biology assays. This article dissects practical workflow enhancements, advanced troubleshooting, and actionable protocol parameters that benchmark its performance against emerging requirements for ecological toxicology research.

• EPZ-6438: A Selective EZH2 Inhibitor for Epigenetic Cancer M

  2026-07-08

  EPZ-6438 is a potent, selective EZH2 inhibitor with nanomolar efficacy in epigenetic cancer research. It targets the PRC2 pathway, reduces H3K27me3, and demonstrates robust activity in both in vitro and in vivo models. This article details the mechanism, applications, and key considerations for deploying EPZ-6438 in oncology workflows.

• SPRTN’s Dual Ubiquitin Binding Enables Rapid DNA-Protein Cro

  2026-07-08

  This study uncovers how the SPRTN protease uses a previously uncharacterized ubiquitin-binding domain to achieve rapid and specific proteolysis of polyubiquitinated DNA-protein crosslinks (DPCs). These findings clarify the molecular basis of substrate recognition in DNA repair and highlight new experimental strategies for investigating protein-DNA interface proteolysis.

• Octyl-α-ketoglutarate: Advancing HIF-1α Modulation in CRC Re

  2026-07-07

  This thought-leadership article explores how Octyl-α-ketoglutarate, a next-generation prolyl hydroxylase substrate, empowers translational researchers to interrogate hypoxia signaling and metabolic vulnerabilities in colorectal cancer (CRC). Integrating mechanistic insights from recent IDH2-driven metabolic reprogramming studies, the article offers experimental guidance, competitive analysis, and a forward-looking perspective for leveraging metabolic modulation in disease models.

• VX-765: Transforming Blood-Brain Barrier Research via Select

  2026-07-07

  Explore how VX-765, a potent selective caspase-1 inhibitor, redefines blood-brain barrier research and inflammation modeling. This article reveals novel insights, practical protocols, and cross-domain opportunities for CNS and immune research.

• Adefovir (GS-0393): Streamlined Workflows for HBV & OAT1 Res

  2026-07-06

  Adefovir (GS-0393) uniquely combines potent HBV DNA polymerase inhibition with validated use as a renal OAT1 transporter probe, enabling robust antiviral and pharmacokinetic workflows. This guide details protocol enhancements, troubleshooting, and optimized data integration for advanced hepatitis B virus research and transporter phenotyping.

• BRD4770 and G9a Inhibition: Precision Epigenetic Strategies

  2026-07-06

  Explore how BRD4770, a G9a histone methyltransferase inhibitor, enables high-precision control of histone H3K9 methylation and senescence pathways in cancer biology. This article uniquely dissects mechanistic insights, advanced assay design, and reference-driven innovations for cancer research.

• Capsaicin in Research: TRPV1 Activation and KDM1A Inhibition

  2026-07-05

  Capsaicin ((E)-Capsaicin) is not just a classic TRPV1 agonist—it’s also a potent, reversible KDM1A/LSD1 inhibitor, unlocking new frontiers in pain, inflammation, and cancer research. This guide translates cutting-edge findings into actionable protocols, highlighting troubleshooting tactics for reproducibility and experimental rigor.

• BMX-IN-1: Precision BMX Kinase Inhibitor for Cancer Research

  2026-07-04

  BMX-IN-1 enables researchers to dissect BMX kinase signaling with unmatched selectivity, unlocking new insights in angiogenesis, cancer progression, and host-pathogen interactions. Discover protocol guidance, applied case studies, and troubleshooting strategies that maximize this irreversible BMX kinase inhibitor’s impact across advanced cellular models.

• β-Pseudouridine: Enhancing Epitranscriptomic Workflows and F

  2026-07-03

  β-Pseudouridine, the C-glycoside isomer of uridine, empowers researchers to stabilize RNA structures and optimize mRNA vaccine development. This guide delivers actionable protocols, troubleshooting strategies, and comparative insights to maximize the translational and epitranscriptomic potential of β-pseudouridine in advanced RNA modification studies.

16298 records 1/1087 page Next 12345 下5页 Last page